The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors. Issue 13 (1st July 2016)
- Record Type:
- Journal Article
- Title:
- The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors. Issue 13 (1st July 2016)
- Main Title:
- The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors
- Authors:
- Keith, John M.
Tichenor, Mark S.
Apodaca, Richard L.
Xiao, Wei
Jones, William M.
Seierstad, Mark
Pierce, Joan M.
Palmer, James A.
Webb, Michael
Karbarz, Mark J.
Scott, Brian P.
Wilson, Sandy J.
Wennerholm, Michelle L.
Rizzolio, Michele
Rynberg, Raymond
Chaplan, Sandra R.
Breitenbucher, J. Guy - Abstract:
- Graphical abstract: The SAR of brain penetration for a series of heteroaryl piperazinyl- and piperadinyl-urea fatty acid amide hydrolase (FAAH) inhibitors is described. Brain/plasma (B/P) ratios ranging from >4:1 to as low as 0.02:1 were obtained through relatively simple structural changes to various regions of the heteroaryl urea scaffold. It was not possible to predict the degree of central nervous system (CNS) penetration from the volumes of distribution ( V d ) obtained from PK experiments as very high V d s did not correlate with high B/P ratios. Similarly, calculated topological polar surface areas (TPSAs) did not consistently correlate with the degree of brain penetration. The lowest B/P ratios were observed for those compounds that were significantly ionized at physiological pH. However, as this class of compounds inhibits the FAAH enzyme through covalent modification, low B/P ratios did not preclude effective central target engagement. Abstract: The SAR of brain penetration for a series of heteroaryl piperazinyl- and piperadinyl-urea fatty acid amide hydrolase (FAAH) inhibitors is described. Brain/plasma (B/P) ratios ranging from >4:1 to as low as 0.02:1 were obtained through relatively simple structural changes to various regions of the heteroaryl urea scaffold. It was not possible to predict the degree of central nervous system (CNS) penetration from the volumes of distribution ( V d ) obtained from pharmacokinetic (PK) experiments as very high V d s did notGraphical abstract: The SAR of brain penetration for a series of heteroaryl piperazinyl- and piperadinyl-urea fatty acid amide hydrolase (FAAH) inhibitors is described. Brain/plasma (B/P) ratios ranging from >4:1 to as low as 0.02:1 were obtained through relatively simple structural changes to various regions of the heteroaryl urea scaffold. It was not possible to predict the degree of central nervous system (CNS) penetration from the volumes of distribution ( V d ) obtained from PK experiments as very high V d s did not correlate with high B/P ratios. Similarly, calculated topological polar surface areas (TPSAs) did not consistently correlate with the degree of brain penetration. The lowest B/P ratios were observed for those compounds that were significantly ionized at physiological pH. However, as this class of compounds inhibits the FAAH enzyme through covalent modification, low B/P ratios did not preclude effective central target engagement. Abstract: The SAR of brain penetration for a series of heteroaryl piperazinyl- and piperadinyl-urea fatty acid amide hydrolase (FAAH) inhibitors is described. Brain/plasma (B/P) ratios ranging from >4:1 to as low as 0.02:1 were obtained through relatively simple structural changes to various regions of the heteroaryl urea scaffold. It was not possible to predict the degree of central nervous system (CNS) penetration from the volumes of distribution ( V d ) obtained from pharmacokinetic (PK) experiments as very high V d s did not correlate with high B/P ratios. Similarly, calculated topological polar surface areas (TPSAs) did not consistently correlate with the degree of brain penetration. The lowest B/P ratios were observed for those compounds that were significantly ionized at physiological pH. However, as this class of compounds inhibits the FAAH enzyme through covalent modification, low B/P ratios did not preclude effective central target engagement. … (more)
- Is Part Of:
- Bioorganic & medicinal chemistry letters. Volume 26:Issue 13(2016)
- Journal:
- Bioorganic & medicinal chemistry letters
- Issue:
- Volume 26:Issue 13(2016)
- Issue Display:
- Volume 26, Issue 13 (2016)
- Year:
- 2016
- Volume:
- 26
- Issue:
- 13
- Issue Sort Value:
- 2016-0026-0013-0000
- Page Start:
- 3109
- Page End:
- 3114
- Publication Date:
- 2016-07-01
- Subjects:
- FAAH -- Covalent inhibition -- Blood brain barrier -- BBB -- Heteroaryl urea -- Rat PK -- Target engagement
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
572 - Journal URLs:
- http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description ↗
http://www.sciencedirect.com/science/journal/0960894X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmcl.2016.05.001 ↗
- Languages:
- English
- ISSNs:
- 0960-894X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7797.xml